Clinical efficacy of delayed-release dimethyl fumarate in relapsing-remitting MS (RRMS) patients with highly active disease: Integrated analysis of the phase 3 DEFINE and CONFIRM studies

Authors
Category Primary study
ConferenceJournal of Neurology
Year 2014
This article has no abstract
Epistemonikos ID: 3d66b91d0fcc7ce8221911187b7c45c0c1a67c15
First added on: Apr 30, 2026